Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
15.19
-0.98 (-6.06%)
At close: Aug 28, 2026, 4:00 PM EDT
15.08
-0.11 (-0.72%)
After-hours: Aug 28, 2026, 7:50 PM EDT
Arcturus Therapeutics Holdings Employees
As of December 31, 2025, Arcturus Therapeutics Holdings had 111 total employees, including 106 full-time and 5 part-time employees. The number of employees decreased by 65 or -36.93% compared to the previous year.
Employees
111
Change (1Y)
-65
Growth (1Y)
-36.93%
Revenue / Employee
$264,577
Profits / Employee
-$840,324
Market Cap
431.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 111 | -65 | -36.93% | 106 | 5 |
| Dec 31, 2024 | 176 | -4 | -2.22% | 174 | 2 |
| Dec 31, 2023 | 180 | 10 | 5.88% | 180 | 0 |
| Dec 31, 2022 | 170 | -7 | -3.95% | 170 | 0 |
| Dec 31, 2021 | 177 | 59 | 50.00% | 177 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Ocugen | 116 |
| Larimar Therapeutics | 71 |
| Atea Pharmaceuticals | 55 |
| Eupraxia Pharmaceuticals | 49 |
| Compass Therapeutics | 39 |
| Fennec Pharmaceuticals | 35 |
| Inhibikase Therapeutics | 35 |
ARCT News
- 18 days ago - Arcturus Therapeutics Holdings Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 23 days ago - Arcturus Therapeutics price target lowered to $20 from $21 at Canaccord - TheFly
- 23 days ago - Arcturus Therapeutics Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 23 days ago - Arcturus Therapeutics Holdings Earnings release: Q2 2026 - Filings
- 23 days ago - Arcturus Therapeutics Holdings Quarterly report: Q2 2026 - Filings
- 23 days ago - Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress - Business Wire
- 4 weeks ago - Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 - Business Wire
- 5 weeks ago - Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference - Business Wire